BCIQ Profiles

Company Profile ReportTarget Profile Report

Genome editing company Precision proposes $100M IPO

With plans to bring an allogeneic CAR T immunotherapy into the clinic, Precision BioSciences Inc. (Durham, N.C.) proposed Friday to raise up to $100 million in an IPO on

Read the full 293 word article

How to gain access

Continue reading with a
two-week free trial.